Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
https://www.zacks.com/stock/news/2249713/are-investors-undervaluing-phibro-animal-health-pahc-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2249713
Apr 03, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Phibro (PAHC) Appears Well Poised on Launches, Vaccine Sales
https://www.zacks.com/stock/news/2237419/phibro-pahc-appears-well-poised-on-launches-vaccine-sales?cid=CS-ZC-FT-analyst_blog|zer_report_update-2237419
Mar 07, 2024 - Phibro (PAHC) is focusing on new developments along with incremental registrations and growing volumes of existing nutritional specialties and vaccine technologies.
0
What Makes Phibro (PAHC) a New Buy Stock
https://www.zacks.com/stock/news/2226352/what-makes-phibro-pahc-a-new-buy-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2226352
Feb 14, 2024 - Phibro (PAHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
0